At what enterprise value was INICEA acquired in 2020?

During the acquisition of INICEA by CLARIANE in 2020, the transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR.

What was the EV/EBITDA of INICEA when it was acquired by CLARIANE?

The estimated EV/EBITDA multiple for INICEA is in the range of 10x - 18x.

When was INICEA acquired by CLARIANE?

INICEA was acquired by CLARIANE in 2020.

What was the EBITDA of INICEA during the acquisition?

INICEA's EBITDA is estimated to be in the range of 10M - 30M EUR.

How is the data for the INICEA acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the INICEA deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.clariane.com/actualites/toutes-les-actualites/acquisition-definitive-d-inicea

← DATABASE

Home Database Healthcare & PharmaINICEA

02/2020

INICEA acquired by CLARIANE

FRANCE Health Providers / Healthcare Facilities / Clinics / Hospitals EV 300M - 700M EUR

Context

Clariane (formerly operating as Korian) has finalized the definitive acquisition of Inicea, a premier psychiatric care provider, from Antin Infrastructure Partners. This landmark healthcare transaction positions the European care and hospitality giant among the top 3 private psychiatry operators in France. By merging Inicea's 19 specialized facilities with its own 11 existing clinics, the group scales its network to 30 specialized psychiatric and addiction clinics, effectively establishing a dedicated fourth business line focused on mental health within its French operations.

INICEA, which reported an EBITDA margin of in 2021, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Inicea is a French private psychiatric and addiction care specialist operating a network of 19 establishments at the time of the transaction, focused on mental health and addictology services. The group has developed a distinctive and innovative approach to ambulatory care, notably through the opening of autonomous day care reception centres (centres d'accueil de jour autonomes), positioning it as a pioneer in outpatient mental health pathways in France. Inicea's clinical model emphasises innovative care pathways developed in close collaboration with medical staff and nursing teams, with a particular focus on patients suffering from psychiatric disorders.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
06/2020	ASKLEPIOS KLINIKEN	RHÖN-KLINIKUM	GERMANY	Clinics / Hospitals
03/2020	ORPEA	TLC GROUP	IRELAND	Nursing Homes
02/2020	VIVALTO VIE	SOLIMAR	SPAIN	Nursing Homes
02/2020	AMUNDI PRIVATE EQUITY / SOCIETE GENERALE CAPITAL PARTENAIRES	VIVALTO VIE	FRANCE	Nursing Homes
01/2020	VIVALTO SANTÉ	MATHILDE MÉDICAL DÉVELOPPEMENT	FRANCE	Clinics / Hospitals
01/2020	ARDIAN	SANTE CIE	FRANCE	Health Providers
12/2019	CIRCLE HEALTH	BMI HEALTHCARE	UNITED KINGDOM	Clinics / Hospitals
07/2019	TRITON PARTNERS	ALERIS	SWEDEN	Clinics / Hospitals
07/2019	NAXICAP PARTNERS / ARDIAN	EMERA	FRANCE	Nursing Homes
07/2019	I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENT	DOMIDEP	FRANCE	Nursing Homes

REFERENCES

Valuation range: EV 300M - 700M EUR

EBITDA range: 10M - 30M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of INICEA by CLARIANE are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.